Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Tactiva Therapeutics Logo
Tactiva Therapeutics Growth Score
59
CB Rank
108798
Heat Score
8
Tactiva Therapeutics is a development stage immuno-oncology company
Founded
obfuscation
PrivateSeries A Buffalo, New York, United States11-50 tactivatherapeutics.com/
Biotechnology
Oncology
Overview

Tactiva Therapeutics
Total Funding
obfuscation
Growth Score
59
Heat Score
8

Total Funding
obfuscation
obfuscation
Series A raised
obfuscation
Growth Score59
-3 pts
in past quarter
Heat Score 8
-8 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Tactiva Therapeutics

CB Rank
108798
Tactiva Therapeutics is a development stage immuno-oncology company
Founded
obfuscation
PrivateSeries A Buffalo, New York, United States11-50 tactivatherapeutics.com/
Biotechnology
Oncology

Funding Rounds

Series A
OBF
in
obfuscation

Key People

Details

Legal Name Tactiva Therapeutics, LLC
Operating Status Active
Company Type For Profit
Founders  Kunle Odunsi, Richard C. Koya
About the Company
Tactiva Therapeutics is an Immuno-Oncology Company Utilizing an Innovative Approach to Adoptive Cell Therapy.
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Next Generation Adoptive Cell Therapy Platform
A cancer immunotherapy platform using genetically modified patient T cells, including CD4 and CD8 T cell receptors, to target and destroy cancer cells.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Tactiva Therapeutics Logo
Series A - Tactiva Therapeutics
3
obfuscation
Panacea VentureSeries A
obfuscation
Series A - Tactiva Therapeutics Logo
Series A - Tactiva Therapeutics
3
obfuscation
Panacea VentureSeries A
obfuscation
Series A - Tactiva Therapeutics Logo
Series A - Tactiva Therapeutics
3
obfuscation
Panacea VentureSeries A
obfuscation
Series A - Tactiva Therapeutics Logo
Series A - Tactiva Therapeutics
3
obfuscation
Panacea VentureSeries A
obfuscation
Series A - Tactiva Therapeutics Logo
Series A - Tactiva Therapeutics
3
obfuscation
Panacea VentureSeries A

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Tactiva Therapeutics Logo
Series A - Tactiva Therapeutics
3
obfuscation
Panacea VentureSeries A
obfuscation
Series A - Tactiva Therapeutics Logo
Series A - Tactiva Therapeutics
3
obfuscation
Panacea VentureSeries A
obfuscation
Series A - Tactiva Therapeutics Logo
Series A - Tactiva Therapeutics
3
obfuscation
Panacea VentureSeries A
obfuscation
Series A - Tactiva Therapeutics Logo
Series A - Tactiva Therapeutics
3
obfuscation
Panacea VentureSeries A
obfuscation
Series A - Tactiva Therapeutics Logo
Series A - Tactiva Therapeutics
3
obfuscation
Panacea VentureSeries A

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 3 Contacts 2

Employee Profiles

News
Technology
View Tech Report

IT Spend

$376.5KThis year, Tactiva Therapeutics is projected to spend $376.5K on IT, according to Aberdeen.

Active Website Tech Count

3Tactiva Therapeutics is actively using 3 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m and  Euro.
Sub-Organizations
Frequently Asked Questions

Where is Tactiva Therapeutics's headquarters? Tactiva Therapeutics is located in Buffalo, New York, United States.Who invested in Tactiva Therapeutics? Tactiva Therapeutics has 3 investors including Panacea Venture and  Viventures.When was the last funding round for Tactiva Therapeutics? Tactiva Therapeutics closed its last funding round on
obfuscation
from a Series A round.Who are Tactiva Therapeutics's competitors? Alternatives and possible competitors to Tactiva Therapeutics may include TScan Therapeutics, Carisma Therapeutics, and  BioNTech.How much funding has Tactiva Therapeutics raised to date? Tactiva Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|